About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(ARR2/Pbsn-MYC)7Key
transgene insertion 7, Katharine Ellwood-Yen
MGI:3785495
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cx1
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(ARR2/Pbsn-MYC)7Key/0
involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J MGI:5662416
tg2
Tg(ARR2/Pbsn-MYC)7Key/? involves: FVB/N MGI:5486199


Genotype
MGI:5662416
cx1
Allelic
Composition
Mirc1tm2.1Aven/Mirc1tm2.1Aven
Tg(ARR2/Pbsn-MYC)7Key/0
Genetic
Background
involves: 129S4/SvJae * C57BL/6 * FVB/N * SJL/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Mirc1tm2.1Aven mutation (1 available); any Mirc1 mutation (6 available)
Tg(ARR2/Pbsn-MYC)7Key mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• prostate volume is reduced compared to Tg(ARR2/Pbsn-MYC)7Key alone
• prostrates from 8 week old males exhibit occasional prostatic intraepithelial neoplasia in contrast to Tg(ARR2/Pbsn-MYC)7Key alone
• invasive prostatic adenocarcinoma is not observed until 14 months of age in contrast to Tg(ARR2/Pbsn-MYC)7Key alone

reproductive system
• prostate volume is reduced compared to Tg(ARR2/Pbsn-MYC)7Key alone
• prostrates from 8 week old males exhibit occasional prostatic intraepithelial neoplasia in contrast to Tg(ARR2/Pbsn-MYC)7Key alone
• invasive prostatic adenocarcinoma is not observed until 14 months of age in contrast to Tg(ARR2/Pbsn-MYC)7Key alone

neoplasm
• prostrates from 8 week old males exhibit occasional prostatic intraepithelial neoplasia in contrast to Tg(ARR2/Pbsn-MYC)7Key alone
• invasive prostatic adenocarcinoma is not observed until 14 months of age in contrast to Tg(ARR2/Pbsn-MYC)7Key alone




Genotype
MGI:5486199
tg2
Allelic
Composition
Tg(ARR2/Pbsn-MYC)7Key/?
Genetic
Background
involves: FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(ARR2/Pbsn-MYC)7Key mutation (2 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• transition to cancer occurs in all male mice by 3-6 months of age and to invasive adenocarcinoma of the prostate after 6 months of age
• mice castrated at 8 months of age (when all have prostate cancer) show evidence of regression and fibrosis at all time points post-castration and the presence of residual tumors that do not express the MYC transgene
• invasive carcinoma of the prostate after 6 months of age (J:85480)
• males develop invasive prostatic adenocarcinomas by 8 months of age (J:223213)
• all male mice develop prostatic intraepithelial neoplasia (mPIN) by 3 months of age; lesions can be seen as early as 2 weeks of age (J:85480)
• mice castrated at 2 months of age (when mPIN lesions are present) exhibit complete regression of mPIN within one month of castration (J:85480)
• prostrates from 8 week old mice exhibit extensive prostatic intraepithelial neoplasia as compared to controls (J:223213)

endocrine/exocrine glands
• prostrate volume is increased as compared to controls
• transition to cancer occurs in all male mice by 3-6 months of age and to invasive adenocarcinoma of the prostate after 6 months of age
• mice castrated at 8 months of age (when all have prostate cancer) show evidence of regression and fibrosis at all time points post-castration and the presence of residual tumors that do not express the MYC transgene
• invasive carcinoma of the prostate after 6 months of age (J:85480)
• males develop invasive prostatic adenocarcinomas by 8 months of age (J:223213)
• all male mice develop prostatic intraepithelial neoplasia (mPIN) by 3 months of age; lesions can be seen as early as 2 weeks of age (J:85480)
• mice castrated at 2 months of age (when mPIN lesions are present) exhibit complete regression of mPIN within one month of castration (J:85480)
• prostrates from 8 week old mice exhibit extensive prostatic intraepithelial neoplasia as compared to controls (J:223213)

reproductive system
• prostrate volume is increased as compared to controls
• transition to cancer occurs in all male mice by 3-6 months of age and to invasive adenocarcinoma of the prostate after 6 months of age
• mice castrated at 8 months of age (when all have prostate cancer) show evidence of regression and fibrosis at all time points post-castration and the presence of residual tumors that do not express the MYC transgene
• invasive carcinoma of the prostate after 6 months of age (J:85480)
• males develop invasive prostatic adenocarcinomas by 8 months of age (J:223213)
• all male mice develop prostatic intraepithelial neoplasia (mPIN) by 3 months of age; lesions can be seen as early as 2 weeks of age (J:85480)
• mice castrated at 2 months of age (when mPIN lesions are present) exhibit complete regression of mPIN within one month of castration (J:85480)
• prostrates from 8 week old mice exhibit extensive prostatic intraepithelial neoplasia as compared to controls (J:223213)





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory